) is thought to be a structural isomer of naturally occurring isoxazolinone derivatives, b-(isoxazolin-5-on-2-yl)-L-alanine (BIA, 2) and b-(isoxazolin-5-on-4-yl)-L-alanine (TAN, 3), but it has not yet been found in nature. BIA (2) was identified in the leguminous genus Lathyrus, Lens and Pisum, was confirmed to be the biosynthetic precursor of the neurotoxin 3-N-oxalyl-L-2,3-diaminopropionic acid (b-ODAP) in grass pea (Lathyrus sativus L.), [1] [2] [3] [4] [5] and was also found to have antimycotic activity.
O-(5-Isoxazolyl)-L-serine (OIS, 1)
is thought to be a structural isomer of naturally occurring isoxazolinone derivatives, b-(isoxazolin-5-on-2-yl)-L-alanine (BIA, 2) and b-(isoxazolin-5-on-4-yl)-L-alanine (TAN, 3), but it has not yet been found in nature. BIA (2) was identified in the leguminous genus Lathyrus, Lens and Pisum, was confirmed to be the biosynthetic precursor of the neurotoxin 3-N-oxalyl-L-2,3-diaminopropionic acid (b-ODAP) in grass pea (Lathyrus sativus L.), [1] [2] [3] [4] [5] and was also found to have antimycotic activity. 6 ) BIA was synthesized from N-Boc-L-serine (9) by Baldwin et al. 7) TAN (3) was isolated from Streptomyces platensis as an antifungal antibiotic, 8) and was also synthesized by Tsubotani et al. 9) However, OIS (1) has not yet been synthesized, in spite of its stable structure.
During the pharmacological study of isoxazolinone derivatives and such related compounds as neurotoxins, which cause crippling human neurolathyrism, we reported that TAN was a potential agonist for glutamate receptors (Glu R) and glutamate transporters (Glu T) as well as b-ODAP, a major causative agent of neurolathyrism, which is caused by eating the grass pea seeds, whereas BIA had almost no activity. [10] [11] [12] Therefore, we have focused on the synthesis of an isomer, OIS (1), to clarify the structure-activity relationship of isoxazolinone compounds. We now report the synthesis and pharmacological activity of 1 in comparison with its two isomers and other related compounds.
Results and Discussion
Synthesis of OIS (1) OIS (1) was synthesized by a Mitsunobu reaction 13) of isoxazolin-5-one (4) with N-Boc-L-serine tert-butyl ester (5) and subsequent deprotection of the coupling product (6) , as shown in Chart 1. Its structure was elucidated by spectroscopic analyses. The IR spectrum of 1 showed an absorption band for carbonyl functionality (1689 cm
Ϫ1
) of an amino acid. (2) or TAN (3), clearly indicated that this carbon is bonded to the isoxazole ring through an oxygen atom (Fig.  1) . Information concerning the coupling position was obtained from the heteronuclear multiple bond correlation (HMBC) spectrum of protected OIS (6) , in which a crosspeak was observed between the oxymethylene proton (d 4.54) and quaternary carbon (d 172.9) of the isoxazole nucleus, indicating that a serine moiety is attached to the C-5 position of the isoxazole ring. This structure was reinforced by comparison of the previously observed NMR data for 2 and 3. 7, 9) Finally, the structure of newly synthesized 1 was concluded to be a positional isomer of 2 and 3, and is represented by the structure formula in Chart 1. Pharmacological Activity of OIS (1) The pharmacological activity of 1 was examined for its activity on Glu R and Glu T by using a Xenopus oocyte-expressing system in comparison with its two isomers, 2 and 3, and the results are summarized in Table 1 . Macroscopic currents were recorded using a two-electrode voltage-clamp method as described previously. 11, 12) In the voltage-clamp experiments using cloned rat Glu R and Glu T expressed in Xenopus oocytes, 1 at 0.1 mM showed weak substrate activity on an excitatory amino acid carrier 1 (EAAC 1), a neuron-type Glu T, while 2 had no activity. OIS (1) also had slight agonistic activity on the glycine site of a N-methyl-D-aspartic acid (NMDA)-subtype of Glu R composed of 1 A and 2B subunits. However, 1 showed almost no activity on the a-amino-3-hydroxy-5-methyl-4-isoxazole propanoic acid (AMPA)-subtype of Glu R composed of a1 and a2 subunits, nor on glutamate/aspartate transporter (GLAST) or glutamate transporter 1 (GLT 1) of Glu T, both being glia-type transporters. As we reported before, 11, 12) 3 had a potential activity against all Glu R and Glu T examined, and b-ODAP also showed agonistic activity on the AMPA receptor, while 2 showed no activity toward Glu R or Glu T (Table 1 ). In summary, 1 had moderate activity toward the glycine site of the NMDA receptor as well as toward the EAAC 1-type Glu T in sharp contrast to its isomer, 3
Synthesis and Pharmacological Activity of O-(5-Isoxazolyl)-L-serine
Amino Acid Analysis of Some Lathyrus and Pisum Species Detection of the newly synthesized 1 in the seedlings and seeds of grass pea (Lathyrus sativus L.), sweet pea (L. odoratus L.), perennial sweet pea (L. latifolius L.) and pea (Pisum sativum L.) was attempted using an automatic amino acid analyzer equipped with a UV detector as described previously, 14) since 2 was identified in these plants 1,2) and 1 had not yet been found. However, 1 could not be detected in these plants examined, under standard operating conditions.
In conclusion, a novel isoxazole compound 1 was synthesized from isoxazolin-5-one (4) and N-Boc-L-serine tertbutyl ester (5) for the first time, and was found to have substrate activity on EAAC 1 as a Glu T, while 1 could not be found in the Lathyrus or Pisum species examined. This suggests that it may be a potential lead compound for the development of new Glu T drugs.
Experimental
Melting points were measured on a Yanagimoto apparatus and are uncorrected. IR spectra were recorded on a JASCO FT/IR-300E spectrometer by the diffuse reflection measurement method. NMR spectra were measured on a JEOL GSX-500a (500 MHz for 1 H and 125 MHz for BIA (2) was obtained from plants as described previously. 1) TAN (3) and b-ODAP were purchased from Takeda Chemical Ind., Ltd., and from Tocris Cookson, Ltd., respectively. All chemicals used in the pharmacological study were dissolved in glass-distilled water.
Isoxazolin-5-one (4) 4 was synthesized from ethyl propiolate (7) via ethyl malonaldehydate oxime (8, 400.5 mg, 3.07 mM) as colorless prisms (180.5 mg, 69.2%) in accordance with the method of Sarlo.
15)
N-Boc-L-serine tert-Butyl Ester (5) 16) A mixed solution of N-Boc-Lserine (9, 1.003 g, 4.89 mM) and N,N-dimethylformamide di-tert-butylacetal (DFBA, 6.21 ml, dϭ0.848, 25.9 mM) in dry benzene (8.0 ml) was refluxed for 19 h under Ar. To the mixture, 5% aq. NaHCO 3 was added and stirred for 30 min, then an adequate amount of CH 3 OH was added to give one layer. After extraction with AcOEt, its fraction was rinsed 3 times with H 2 O and once with sat. NaCl aq., which was dried over MgSO 4 were dissolved in 1.0 ml of tetrahydrofuran (THF) at 0°C under Ar, then diisopropyl azodicarboxylate (DIAD, 0.045 ml, dϭ1.027, 0.36 mM) was added dropwise in accordance with the Mitsunobu reaction.
13) The resulting mixture was stirred at room temperature for 6 h. To the reaction mixture, water was added and extracted with AcOEt. The AcOEt solution was rinsed 3 times with water and once with sat. NaCl aq. After drying over MgSO 4 , the filtrated solvent was removed in vacuo to give a yellow oil (283. 
. Pharmacological Activity Assay This assay of newly synthesized 1 and related compounds was performed using a Xenopus oocyte-expressing system as previously described. 11, 12) Amino Acid Analysis Selected Lathyrus and Pisum seeds were germinated in the dark at 25-26°C. After 6 or 7 d, the seedlings were collected and extracted in 75% EtOH. Detection of 1 in the seedlings and seeds was attempted using an automatic amino acid analyzer (Hitachi 835-10) equipped with a UV detector (265 nm) under standard operating conditions as described previously: 14) 1 was eluted at about 31 min from the column, and 2 and 3 were eluted at about 23 and 37 min, respectively, at a flow rate of 0.275 ml per min.
